The company behind Claude once promised to build safe and ethical tech. Pete Hegseth is putting that promise to the test.

As artificial intelligence continues to reshape industries at an unprecedented pace, venture capitalists face a critical knowledge gap: understanding how humans and AI systems collaborate most ...

"This real-world retrospective analysis clearly demonstrates that HCL provides significant improvements in glycaemic control, specifically HbA1c [A1c] and TIR [time in range], without increasing time ...